Citations

Clear

2511 citation(s) found for "Ge, Yang".

The incidence rates and survival of gallbladder cancer in the USA
Jaruvongvanich, Veeravich , Yang, Ju Dong , Peeraphatdit, Thoetchai , Roberts, Lewis R. , Yang, Ju Dong , Roberts, Lewis R

Mayo Clinic

European Journal of Cancer Prevention | July 4, 2017 | Volume: 28 | Issue: 1 | Pages: 1-9

10.1097/cej.0000000000000402 | PMID 28683010 Get It

Gallbladder cancer is a rare malignancy in most countries. The racial and sociodemographic factors associated with its incidence and survival are poorly defined. We aimed to investigate population-based gallbladder cancer incidence and survival trends on the basis of clinical characteristics and sociodemographic factors in the USA. Gallbladder cancer incidence and survival data from 2001 to 2012 were obtained from 18 registries of the Surveillance, Epidemiology, and End Results database. Incidence rates and Joinpoint trends were calculated by demographic subgroup. Survival trends were assessed using Cox proportional hazard models. A total of 7769 patients were identified. The overall gallbladder cancer incidence rates did not significantly change during the 2001–2012 period. Incidence rates were three times higher in Hispanics and 1.6 times higher in Blacks compared with Whites. Over the time period, incidence rates significantly increased among Blacks and decreased among Hispanics. Male sex [hazard ratio (HR): 1.10, 95% confidence interval (CI): 1.03–1.17], older age (HR: 1.73, 95% CI: 1.53–1.96), and single and divorced statuses (HR: 1.19, 95% CI: 1.09–1.30 and 1.12, 95% CI: 1.01–1.24) were independently associated with shorter overall survival, whereas higher education (HR: 0.89, 95% CI: 0.82–0.97) and higher income (HR: 0.89, 95% CI: 0.82–0.96) were associated with longer survival. Furthermore, overall survival has improved in all races/ethnicities except for Hispanics and Blacks. The overall incidence rates for gallbladder cancer were stable during 2001–2012. Hispanics have the highest incidence rates, but the incidence rates in Blacks are on the rise.
Immunoultrastructural Demonstration of Prostatic Acid Phosphatase Isoenzyme 2 in Prostatic Carcinoma
Lin, Chin‐Tarng , Liu, Jiewen, Song, Guoxing, Wu, Jang‐Yen , Lam, Kwok‐Wai , Yam, Lung T., Li, Ching-Yang

Mayo Clinic

Journal of Urology | June 30, 2017 | Volume: 136 | Issue: 1 Part 1 | Pages: 173-180

10.1016/s0022-5347(17)44766-5 | PMID 3712607 Get It

The impact of incontinence etiology on artificial urinary sphincter outcomes
Miller, Adam R. , Linder, Brian J. , Rangel, Laureano J. , Yang, David Y. , Elliott, Daniel S. , Yang Md, David , Linder, Brian J

Mayo Clinic

Investigative and Clinical Urology | June 30, 2017 | Volume: 58 | Issue: 4 | Pages: 241

10.4111/icu.2017.58.4.241 | PMID 28681033 Get It

Platelet‐derived growth factor regulates YAP transcriptional activity via Src family kinase dependent tyrosine phosphorylation
Smoot, Rory L. , Werneburg, Nathan W., Yang, Lin , Mehner, Christine , Graham, Rondell P. , Bronk, Steven F., Truty, Mark J. , Sugihara, Takaaki, Hernandez, Matthew C. , Sugihara, Takaaki , Gores, Gregory J. , Smoot, Rory L , Graham, Rondell P

Mayo Clinic

Journal of Cellular Biochemistry | June 29, 2017 | Volume: 119 | Issue: 1 | Pages: 824-836

10.1002/jcb.26246 | PMID 28661054 Get It

AbstractThe Hippo pathway effector YAP is implicated in the pathogenesis of cholangiocarcinoma (CCA). The Hippo pathway relies on signaling cross talk for its regulation. Given the importance of platelet derived growth factor receptor (PDGFR) signaling in CCA biology, our aim was to examine potential YAP regulation by PDGFR. We employed human and mouse CCA specimens and cell lines for these studies. Initially, we confirmed upregulation of PDGFRβ and PDGFR ligands in human and mouse CCA specimens and cell lines. YAP, a transcriptional co‐activator, was localized to the nucleus in human CCA specimens and a cell line, as well as patient derived xenografts (PDX). PDGFR pharmacologic inhibition led to a redistribution of YAP from the nucleus to cytosol and downregulation of YAP target genes in a human CCA cell line. siRNA silencing of PDGFR‐β similarly downregulated YAP target genes. YAP activation (nuclear localization and target gene expression) was regulated by Src family kinases (SFKs) downstream of PDGFR. SFK activity resulted in phosphorylation of YAP on tyrosine357 (YAPY357). The importance of YAPY357 phosphorylation in regulating YAP activation was confirmed utilizing the SB‐1 cell line, a mouse cell line expressing YAP S127A precluding canonical serine phosphorylation. PDGFR inhibition decreased cellular abundance of the survival protein Mcl‐1, a known YAP target gene, and accordingly increased cell death in CCA cells in vitro and in vivo. These preclinical data demonstrate that a PDGFR‐SFK cascade regulates YAP activation via tyrosine phosphorylation in CCA. Inhibiting this cascade may provide a viable therapeutic strategy for this human malignancy.
Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy
Debes, José D. , Chan, Aaron J., Balderramo, Domingo , Kikuchi, Luciana , Ballerga, Esteban González , Prieto, Jhon , Tapias, Mónica, Idrovo, Víctor, Davalos, Milagros B., Cairo, Fernando , Barreyro, Fernando Javier , Paredes, Sebastián , Hernández, Nelia , Avendaño, Karla, Ferrer, Javier Díaz , Yang, Ju Dong , Carrera, Enrique , Garcia, Jairo A., Mattos, Ângelo Zambam de , Hirsch, Bruno Salomão , Gonçalves, Pablo T., Carrilho, Flair José , Roberts, Lewis R. , Hernández, Nelia , Yang, Ju Dong , Roberts, Lewis R

Mayo Clinic

Liver International | June 22, 2017 | Volume: 38 | Issue: 1 | Pages: 136-143

10.1111/liv.13502 | PMID 28640517 Get It

AbstractBackground & AimsHepatocellular carcinoma (HCC) is the second leading cause of cancer‐related death worldwide. Most studies addressing the epidemiology of HCC originate from developed countries. This study reports the preliminary findings of a multinational approach to characterize HCC in South America.MethodsWe evaluated 1336 HCC patients seen at 14 centres in six South American countries using a retrospective study design with participating centres completing a template chart of patient characteristics. The diagnosis of HCC was made radiographically or histologically for all cases according to institutional standards. Methodology of surveillance for each centre was following AASLD or EASL recommendations.ResultsSixty‐eight percent of individuals were male with a median age of 64 years at time of diagnosis. The most common risk factor for HCC was hepatitis C infection (HCV, 48%), followed by alcoholic cirrhosis (22%), Hepatitis B infection (HBV, 14%) and NAFLD (9%). We found that among individuals with HBV‐related HCC, 38% were diagnosed before age 50. The most commonly provided therapy was transarterial chemoembolization (35% of HCCs) with few individuals being considered for liver transplant (<20%). Only 47% of HCCs were diagnosed during surveillance, and there was no difference in age of diagnosis between those diagnosed incidentally vs by surveillance. Nonetheless, being diagnosed during surveillance was associated with improved overall survival (P = .01).ConclusionsOur study represents the largest cohort to date reporting characteristics and outcomes of HCC across South America. We found an important number of HCCs diagnosed outside of surveillance programmes, with associated increased mortality in those patients.
Risk of Post-transplant Hepatocellular Carcinoma Recurrence Is Higher in Recipients of Livers From Male Than Female Living Donors
Han, Sangbin , Yang, Ju Dong , Choi, Gyu Sung, Jung, Gangha, Ahn, Joonghyun , Kim, Seonwoo , Ko, Justin Sangwook , Gwak, Mi Sook , Kwon, Choon Hyuck David , Leise, Michael D. , Kim, Gaab Soo , Yang, Ju Dong , Sinn, Dong Hyun , Kim, Jong Man , Gwak, Geum‐Youn , Heimbach, Julie K.

Mayo Clinic

Annals of Surgery | June 17, 2017 | Volume: 268 | Issue: 6 | Pages: 1043-1050

10.1097/sla.0000000000002318 | PMID 28628564 Get It

Objective: To evaluate the relationship between donor sex and hepatocellular carcinoma (HCC) recurrence after living donor liver transplantation. Background: HCC shows a male predominance in incidence and recurrence after tumor resection due to sex differences in hepatic sex hormone receptors. There have been no studies evaluating the importance of donor sex on post-transplant HCC recurrence. Methods: Of 384 recipients of livers, from living donors, for HCC: 104/120 who received grafts from female donors were matched with 246/264 who received grafts from male donors using propensity score matching, with an unfixed matching ratio based on factors like tumor biology. Survival analysis was performed with death as a competing risk event. The primary outcome was overall HCC recurrence. Results: The median follow-up time was 39 months. Before matching, recurrence probability at 1/2/5 years after transplantation was 6.1/9.7/12.7% in recipients with female donors and 11.7/19.2/25.3% in recipients with male donors. Recurrence risk was significantly higher with male donors in univariable analysis (hazard ratio [HR] = 2.04 [1.15–3.60], P = 0.014) and multivariable analysis (HR=2.10 [1.20–3.67], P = 0.018). In the matched analysis, recurrence risk was also higher with male donors (HR=1.92 [1.05–3.52], P = 0.034): both in intrahepatic recurrence (HR=1.92 [1.05–3.51], P = 0.034) and extrahepatic recurrence (HR=1.93 [1.05–3.52], P = 0.033). Multivariable analysis confirmed the significance of donor sex (HR=2.08 [1.11–3.91], P = 0.023). Interestingly, the significance was lost when donor age was >40 years. Two external cohorts validated the significance of donor sex. Conclusions: Donor sex appears to be an important graft factor modulating HCC recurrence after living donor liver transplantation.
Early‐life decline in neurogenesis markers and age‐related changes of TrkB splice variant expression in the human subependymal zone
Weissleder, Christin , Kondo, Mari , Yang, Chunhui , Fung, Samantha J., Rothmond, Debora A. , Wong, Matthew Wai Kin , Halliday, Glenda M. , Herman, Mary M., Weickert, Cynthia Shannon , Kleinman, Joel E , Webster, Maree J. , Halliday, Glenda , Weissleder, Christin

Mayo Clinic

European Journal of Neuroscience | June 14, 2017 | Volume: 46 | Issue: 2 | Pages: 1768-1778

10.1111/ejn.13623 | PMID 28612959 Get It

AbstractNeurogenesis in the subependymal zone (SEZ) declines across the human lifespan, and reduced local neurotrophic support is speculated to be a contributing factor. While tyrosine receptor kinase B (TrkB) signalling is critical for neuronal differentiation, maturation and survival, little is known about subependymal TrkB expression changes during postnatal human life. In this study, we used quantitative PCR and in situ hybridisation to determine expression of the cell proliferation marker Ki67, the immature neuron marker doublecortin (DCX) and both full‐length (TrkB‐TK+) and truncated TrkB receptors (TrkB‐TK‐) in the human SEZ from infancy to middle age (n = 26–35, 41 days to 43 years). We further measured TrkB‐TK+ and TrkB‐TK‐ mRNAs in the SEZ from young adulthood into ageing (n = 50, 21–103 years), and related their transcript levels to neurogenic and glial cell markers. Ki67, DCX and both TrkB splice variant mRNAs significantly decreased in the SEZ from infancy to middle age. In contrast, TrkB‐TK‐ mRNA increased in the SEZ from young adulthood into ageing, whereas TrkB‐TK+ mRNA remained stable. TrkB‐TK‐ mRNA positively correlated with expression of neural precursor (glial fibrillary acidic protein delta and achaete‐scute homolog 1) and glial cell markers (vimentin and pan glial fibrillary acidic protein). TrkB‐TK+ mRNA positively correlated with expression of neuronal cell markers (DCX and tubulin beta 3 class III). Our results indicate that cells residing in the human SEZ maintain their responsiveness to neurotrophins; however, this capability may change across postnatal life. We suggest that TrkB splice variants may differentially influence neuronal and glial differentiation in the human SEZ.
Shear elasticity and shear viscosity imaging in viscoelastic phantoms
Yang, Yiqun , McGough, Robert J., Song, Pengfei , Chen, Shigao , Urban, Matthew W.

Mayo Clinic

The Journal of the Acoustical Society of America | June 10, 2017 | Volume: 141 | Issue: 5_Supplement | Pages: 3720-3721

10.1121/1.4988148 Get It

Shear wave elasticity imaging determines the mechanical parameters of soft tissue by analyzing measured shear waves induced by an acoustic radiation force. Currently, the widely used time-of-flight method calculates the correlation between shear waveforms at adjacent lateral observation points to estimate the shear elasticity value. Although this method provides accurate estimates of the shear elasticity in purely elastic media, our experience suggests that this approach overestimates the shear elasticity values in viscoelastic media because the effects of diffraction, attenuation, and dispersion are not taken into account. To address this problem, we have developed an approach that directly accounts for all of these effects when estimating the shear elasticity. This new approach simulates shear waveforms using a Green’s function-based approach with a Voigt model, while the shear elasticity and viscosity values are estimated using an optimization-based approach by comparing measured shear waveforms with simulated shear waveforms in the time-domain. This operation is then performed on a point-by-point basis to generate images. The results indicate that there is good agreement between the simulated and measured shear velocity waveforms, and that this approach yields improved images of the shear elasticity and shear viscosity. [Work supported, in part, by NIH Grant R01DK092255.]
EXPRESSION OF LAG‐3 DEFINES EXHAUSTION OF INTRATUMORAL PD‐1+ T CELLS AND CORRELATES WITH POOR OUTCOME IN FOLLICULAR LYMPHOMA
Kim, Hui Ji , Price-Troska, Tammy, Jalali, Shahrzad , Novak, Anne J. , Ansell, Stephen M. , Yang, Zhi-Zhang , Villasboas, José C. , Price-Troska, Tammy

Mayo Clinic

Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 260-261

10.1002/hon.2438_128 Get It